Our efficacy data with PKP2 gene therapy and mechanistic analyses shed more light on understanding ARVC etiology and in practice, may help patients and physicians to make decisions regarding disease management and treatment. The gene discussed is PKP2; the disease is arrhythmogenic right ventricular cardiomyopathy.